Skip to main content
. 2017 Sep 8;9(1):428–441. doi: 10.18632/oncotarget.20787

Table 3. Cox proportional hazard model for the whole cohort.

Clinical characteristics Overall survival Prostate cancer-specific survival
HR 95% CI P HR 95% CI P
Age at the time of diagnosis, year 1.016 0.98-1.053 0.401 0.999 0.951-1.05 0.976
Year of diagnosis 1.114 1.01-1.228 0.030 1.06 0.927-1.211 0.395
PSA, ng/mL 0.996 0.984-1.008 0.530 1.003 0.989-1.016 0.702
T staging 1.897 1.179-3.054 0.008 1.87 1.018-3.436 0.044
N staging 0.255 0.029-2.238 0.218 0.767 0.083-7.062 0.815
M staging 0.686 0.231-2.037 0.497 0.396 0.087-1.802 0.231
Gleason score 0.966 0.862-1.082 0.546 0.924 0.796-1.072 0.295
Management approach 0.509 0.173-1.501 0.221 1.096 0.296-4.064 0.891

95% CI, 95% confidence interval; HR, hazard ratio.